Structurally Modified Bioactive Peptide Inhibits SARS-CoV-2 Lentiviral Particles Expression
Coronavirus disease 2019 (COVID-19), the current global pandemic is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Various pharmaceuticals are being developed to counter the spread of the virus. The strategy of repurposing known drugs and bioactive molecules is a rational ap...
Saved in:
Main Authors: | Khushwant S. Bhullar (Author), Manal A. Nael (Author), Khaled M. Elokely (Author), Steven J. Drews (Author), Jianping Wu (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Establishment of a pseudovirus neutralization assay based on SARS-CoV-2 S protein incorporated into lentiviral particles
by: Sheng Wang, et al.
Published: (2022) -
Spent Hen Muscle Protein-Derived RAS Regulating Peptides Show Antioxidant Activity in Vascular Cells
by: Hongbing Fan, et al.
Published: (2021) -
Cell-specific delivery of CRISPR-Cas9 with pseudotyped lentiviral particles: Just change the envelope
by: Ángela Covo-Vergara, et al.
Published: (2024) -
Marine Bioactive Peptides-Structure, Function, and Application
Published: (2023) -
A Lentiviral Vector Expressing Japanese Encephalitis Virus-like Particles Elicits Broad Neutralizing Antibody Response in Pigs.
by: Mélissanne de Wispelaere, et al.
Published: (2015)